# Speciality Medicines Ltd (SPML)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹269.85
Day Change: -5%
52W High: ₹381.2
52W Low: ₹121.1
Market Cap: ₹237 Cr

## Valuation
P/E: 27.54
P/B: 4.76
EPS: ₹9.8
Book Value: ₹56.67
Dividend Yield: 0%

## Returns
1Y Return: 0%

## Profitability
ROE: 45%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Speciality Medicines Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Speciality Medicines Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Shareholder Meeting / Postal Ballot-Outcome of EGM
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- BSE Filing: Shareholder Meeting / Postal Ballot-Outcome of EGM

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-17T03:26:10.304Z
Price History Updated: 2026-05-18T22:59:35.233Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-18T22:59:35.233Z
Quant Updated: 2026-05-18T22:59:35.233Z
Sentiment Updated: 2026-05-18T22:59:35.233Z
Financials Status: current
Financials Updated: 2026-05-18T12:30:01.148Z
Financials Last Attempt: 2026-05-18T12:30:01.148Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2022)
Revenue: ₹40 Cr
Operating Profit: ₹2 Cr (OPM 5.36%)
Net Profit: ₹1 Cr
Tax: ₹1 Cr

## Annual P&L History
FY 2022: Rev ₹40Cr | PAT ₹1Cr | OPM 5.36%
FY 2023: Rev ₹23Cr | PAT ₹2Cr | OPM 14.22%
FY 2024: Rev ₹28Cr | PAT ₹3Cr | OPM 18.31%

## Balance Sheet (FY 2022)
Total Assets: ₹6 Cr
Total Liabilities: ₹4 Cr
Borrowings: ₹1 Cr
Cash: ₹undefined Cr

---
Source: rupiya.io/stocks/spml
Disclaimer: For research and education only. Not investment advice.